ZA963098B - Method for treating dyskinesias. - Google Patents

Method for treating dyskinesias.

Info

Publication number
ZA963098B
ZA963098B ZA9603098A ZA963098A ZA963098B ZA 963098 B ZA963098 B ZA 963098B ZA 9603098 A ZA9603098 A ZA 9603098A ZA 963098 A ZA963098 A ZA 963098A ZA 963098 B ZA963098 B ZA 963098B
Authority
ZA
South Africa
Prior art keywords
treating
treating dyskinesias
methyl
dyskinesias
thienoä2
Prior art date
Application number
ZA9603098A
Other languages
English (en)
Inventor
Junior Charles Merritt Beasley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA963098B publication Critical patent/ZA963098B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Saccharide Compounds (AREA)
ZA9603098A 1995-04-21 1996-04-18 Method for treating dyskinesias. ZA963098B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/422,177 US5776928A (en) 1995-04-21 1995-04-21 Method for treating dyskinesias with olanzapine

Publications (1)

Publication Number Publication Date
ZA963098B true ZA963098B (en) 1997-10-20

Family

ID=23673720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603098A ZA963098B (en) 1995-04-21 1996-04-18 Method for treating dyskinesias.

Country Status (11)

Country Link
US (1) US5776928A (fr)
EP (1) EP0738514B1 (fr)
JP (1) JPH11504014A (fr)
AT (1) ATE247966T1 (fr)
AU (1) AU5555596A (fr)
CA (1) CA2218062A1 (fr)
DE (1) DE69629618T2 (fr)
ES (1) ES2206544T3 (fr)
IL (1) IL117971A (fr)
WO (1) WO1996032948A1 (fr)
ZA (1) ZA963098B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274636B1 (en) * 1995-09-29 2001-08-14 Eli Lilly And Company Method for treating a tic disorder
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
AU752552C (en) * 1997-09-30 2003-09-11 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20050153954A1 (en) * 2002-04-23 2005-07-14 Reguri Buchi R. Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
SI21270A (sl) * 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US20050079166A1 (en) 2003-05-21 2005-04-14 Alexza Molecular Delivery Corporation Self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
EP2121088B1 (fr) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
CA2218062A1 (fr) 1996-10-24
US5776928A (en) 1998-07-07
AU5555596A (en) 1996-11-07
EP0738514A1 (fr) 1996-10-23
DE69629618D1 (de) 2003-10-02
JPH11504014A (ja) 1999-04-06
IL117971A (en) 1999-12-31
WO1996032948A1 (fr) 1996-10-24
EP0738514B1 (fr) 2003-08-27
IL117971A0 (en) 1996-08-04
ES2206544T3 (es) 2004-05-16
ATE247966T1 (de) 2003-09-15
DE69629618T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
IL117971A0 (en) Method for treating dyskinesias
HUP9801777A3 (en) Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
GB2313835A (en) Process and crystal forms of 2-Methyl-Thieno-Benzodiazepine
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
AU5801996A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
ZA966603B (en) Therapeutic method.
NZ332037A (en) Olanzapine for treating migraine pain
EP0911028A3 (fr) Methode por le traitement de la disfonctionnement sexuelle
PT828494E (pt) Compostos farmaceuticos
ES2185777T3 (es) Tratamiento de la anorexia.
ZA964198B (en) Treatment regime for skin.
GB9524942D0 (en) Drug therapy
AU2874497A (en) Balanites aegyptiaca method of treatment
AU6896198A (en) Method for treating cerebral focal stroke
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
AU6838596A (en) Drug for treating glaucoma
ZA968524B (en) Therapeutic method.
AU2067297A (en) Method for treating substance abuse
ZA963472B (en) Method of treatment.
ZA965884B (en) 2.[2-(Dimethylamino)ethyl]-8,8-dipropyl-2-azaspiro[4,5]-decane dimaleate
AUPN448595A0 (en) Medicated mask
ZA965310B (en) Therapeutic compounds.
ZA9610335B (en) Amidinopyrroline derivatives, processes for their production and pharmaceutical agents containing these compounds.